Miguel A. Piris

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 90 Citations 29,818 415 World Ranking 7649 National Ranking 102

Overview

What are the main themes of his work throughout his whole career to date

Miguel A. Piris undertakes multidisciplinary investigations into Lymphoma and CD30 in his work. Miguel A. Piris conducts interdisciplinary study in the fields of Pathology and Differential diagnosis through his research. Miguel A. Piris performs multidisciplinary study in Differential diagnosis and Pathology in his work. His research on Genetics frequently connects to adjacent areas such as Aggressive lymphoma. In most of his Aggressive lymphoma studies, his work intersects topics such as Immunology. His work in Immunology is not limited to one particular discipline; it also encompasses T-cell lymphoma. He conducts interdisciplinary study in the fields of T-cell lymphoma and Cancer through his research. His Cancer study frequently draws connections to adjacent fields such as Suppressor. Suppressor connects with themes related to Genetics in his study.

Miguel A. Piris most often published in these fields:

Lymphoma (75.00%)
Pathology (62.50%)
Genetics (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet.
Nature Genetics (2005)

2167 Citations

International network of cancer genome projects

Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
(2010)

1839 Citations

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde.
Nature (2011)

1720 Citations

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris.
Clinical Cancer Research (2009)

791 Citations

Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Andrés J. M. Ferreri;Elías Campo;John F. Seymour;Rein Willemze.
British Journal of Haematology (2004)

593 Citations

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.

Tomás Álvaro;Marylène Lejeune;Ma Teresa Salvadó;Ramón Bosch.
Clinical Cancer Research (2005)

522 Citations

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green.
Blood (2013)

491 Citations

Cell cycle deregulation in B-cell lymphomas.

Margarita Sánchez-Beato;Abel Sánchez-Aguilera;Miguel A. Piris.
Blood (2003)

490 Citations

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

Verònica Fernàndez;Olga Salamero;Blanca Espinet;Francesc Solé.
Cancer Research (2010)

482 Citations

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.

Bosch F;López-Guillermo A;Campo E;Ribera Jm.
Cancer (1998)

448 Citations

If you think any of the details on this page are incorrect, let us know.